¼¼°èÀÇ º­·è ¹× Áøµå±â ±¸Á¦¾à ½ÃÀå
Flea and Tick Control Medication
»óǰÄÚµå : 1774846
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 477 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è º­·è ¹× Áøµå±â ±¸Á¦¾à ½ÃÀåÀº 2030³â±îÁö 100¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 70¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â º­·è ¹× Áøµå±â ±¸Á¦¾à ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 6.2%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 100¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Ãò¾îºíÀº CAGR 7.4%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 64¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ºÇÁ·¹ÀÌÁ¦ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 4.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 19¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ º­·è ¹× Áøµå±â ±¸Á¦¾à ½ÃÀåÀº 2024³â¿¡ 19¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 21¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 10.0%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.0%¿Í 6.2%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.1%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ º­·è ¹× Áøµå±â ±¸Á¦¾à ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

º­·è Áøµå±â ±¸ÃæÁ¦ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

º­·è ¹× Áøµå±â ±¸ÃæÁ¦ ½ÃÀåÀº ¹Ý·Áµ¿¹° »çÀ° ¼ö Áõ°¡, ¹Ý·Áµ¿¹° °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, º­·è ¹× Áøµå±â ¸Å°³ ÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ÜºÎ ±â»ýÃæÀº ÇǺΠ°¨¿°, ºóÇ÷, ¶óÀÓº´, ¿¡¸®Å°¾ÆÁõ°ú °°Àº ¸Å°³¼º Áúȯ µî ¹Ý·Áµ¿¹°¿¡°Ô ½É°¢ÇÑ °Ç°­ À§ÇèÀ» ÃÊ·¡ÇÕ´Ï´Ù. µµ½ÃÈ­·Î ÀÎÇØ Àΰ£°ú µ¿¹°ÀÇ »óÈ£°ü°è°¡ ¹ÐÁ¢ÇØÁö¸é¼­ Àμö°øÅëÀü¿°º´ ÀüÆÄ¿¡ ´ëÇÑ ¿ì·Á°¡ Ä¿Áö¸é¼­ È¿°úÀûÀÎ º­·è ¹× Áøµå±â ÅðÄ¡ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ý·Áµ¿¹° º¸ÇèÀÇ º¸Àå ¹üÀ§¿Í µ¿¹° ÀÇ·á ¼­ºñ½ºÀÇ È®´ë·Î °íǰÁúÀÇ ±â»ýÃæ Ä¡·á°¡ ´õ¿í Ä£¼÷ÇØÁö°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ ¿¹¹æ ÀǷḦ ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, º­·è ¹× Áøµå±â ±¸ÃæÁ¦ ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

º­·è Áøµå±â ±¸ÃæÁ¦´Â ¾î¶² ±â¼ú ¹ßÀüÀ¸·Î °³¼±µÇ°í Àִ°¡?

µ¿¹°¿ë ÀǾàǰ, »ý¸í°øÇÐ, ¼­¹æÇü Á¦Á¦ÀÇ ±â¼ú Çõ½ÅÀº º­·è Áøµå±â ±¸ÃæÁ¦ÀÇ È¿°ú¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. À̼ӻçÁ¹¸°°è ¾à¹°À» ÇÔÀ¯ÇÑ Ãò¾îºí Á¤Á¦¿Í °°Àº Àå±â Áö¼ÓÇü °æ±¸¿ë Ä¡·áÁ¦ÀÇ °³¹ß·Î ¹Ý·Áµ¿¹°ÀÇ ¼øÀÀµµ°¡ Çâ»óµÇ¾î ÇÑ ´Þ°£ ¿¹¹æÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ¶ÇÇÑ, ¹æ¼ö Á¦ÇüÀ» °³¼±ÇÑ ¿Ü¿ëÁ¦´Â ¸ñ¿åÀ̳ª ¼ö¿µ ÈÄ¿¡µµ È¿°ú°¡ Áö¼ÓµÇ¸ç, AI¸¦ Ȱ¿ëÇÑ ½Å¾à °³¹ß·Î º­·è Áøµå±âÀÇ ½Å°æ°è¸¦ º¸´Ù ƯÀÌÀûÀ¸·Î Ÿ°ÙÆÃÇÏ´Â »õ·Î¿î Ȱ¼º ¼ººÐÀÇ °³¹ßÀÌ °¡´ÉÇØÁ® ºÎÀÛ¿ëÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °ïÃæ¼ºÀåÁ¶ÀýÁ¦(IGR) ¹× »ý¹°ÇÐÀû ¹æÁ¦Á¦(õ¿¬ À¯·¡ ±âÇÇÁ¦ µî)ÀÇ ¹ßÀüÀ¸·Î ±âÁ¸ È­Çй°Áú ±â¹Ý Ä¡·áÁ¦¸¦ ´ëüÇÒ ¼ö ÀÖ´Â ¾ÈÀüÇÑ Ä¡·á¹ýÀÌ Á¦°øµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº º­·è Áøµå±â ÅðÄ¡¸¦ º¸´Ù È¿°úÀûÀ̰í, Æí¸®Çϸç, ¹Ý·Áµ¿¹° ģȭÀûÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù.

±ÔÁ¦¿Í ½ÃÀå µ¿ÇâÀº º­·è Áøµå±â ±¸ÃæÁ¦¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

FDA(¹Ì±¹), EMA(À¯·´), APVMA(È£ÁÖ)¿Í °°Àº ±ÔÁ¦ ´ç±¹Àº º­·è ¹× Áøµå±â ±¸ÃæÁ¦ Á¦Ç°ÀÇ ¾ÈÀü¼º°ú È¿°ú¿¡ ´ëÇÑ ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» Á¦½ÃÇϰí ÀÖ½À´Ï´Ù. õ¿¬ ¹× À¯±â³ó Æê Äɾ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½Ä¹°¼º º­·è ±¸ÃæÁ¦¿Í ¿¡¼¾¼È ¿ÀÀÏÀÌ ÇÔÀ¯µÈ Á¦Çü¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿Â¶óÀÎ ¼öÀÇÇÐ Ç÷§ÆûÀ» ÅëÇØ º­·è ¹× Áøµå±â ±¸ÃæÁ¦¸¦ ½±°Ô ±¸ÇÒ ¼ö ÀÖ´Â ±¸µ¶Çü ¹Ý·Áµ¿¹° ÄÉ¾î ¼­ºñ½º°¡ µîÀåÇϸ鼭 º­·è ¹× Áøµå±â ±¸ÃæÁ¦¸¦ ½±°Ô ±¸ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÇÁ¸®¹Ì¾ö Æê ÇコÄÉ¾î ºÐ¾ßÀÇ ¼ºÀåÀº º­·è, Áøµå±â, ½ÉÀ庴, Àå³» ±â»ýÃæ¿¡ ´ëÇÑ ´ÙÁß ±â»ýÃæ ¿¹¹æÀ» Á¦°øÇÏ´Â º¹ÇÕ Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã°¡ °­È­µÇ¸é¼­ ½ÃÀåÀº º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀ̸ç Åõ¿©°¡ °£ÆíÇÑ Ä¡·á¹ýÀ¸·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù.

º­·è Áøµå±â ±¸ÃæÁ¦ ½ÃÀåÀÇ ÇâÈÄ ¼ºÀå µ¿·ÂÀº?

º­·è-Áøµå±â ±¸ÃæÁ¦ÀÇ ¹Ì·¡´Â AI¸¦ Ȱ¿ëÇÑ µ¿¹°¿ë ÀǾàǰ °³¹ß, Àå±â Áö¼ÓÇü Á¦Á¦ÀÇ ¹ßÀü, ¹Ý·Áµ¿¹° ¿ø°Ý ÀÇ·á ¼­ºñ½º µµÀÔ È®´ë¿¡ ÀÇÇØ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. º­·è°ú Áøµå±âÀÇ È°µ¿À» ½Ç½Ã°£À¸·Î °¨ÁöÇÒ ¼ö ÀÖ´Â ¼¾¼­°¡ ³»ÀåµÈ ½º¸¶Æ® ¹Ý·Áµ¿¹° ¸ñ°ÉÀÌÀÇ ÅëÇÕÀº ±â»ýÃæ ÅðÄ¡¿¡ Çõ¸íÀ» ÀÏÀ¸Å³ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àü ¼¼°è ¹Ý·Áµ¿¹° ÇコÄÉ¾î ½ÃÀå, ƯÈ÷ ½ÅÈï±¹ ½ÃÀåÀÇ È®´ë´Â Àú·ÅÇÑ °¡°Ý¿¡ È¿°úÀûÀÎ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ´Â »õ·Î¿î ±âȸ¸¦ âÃâÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, Áö¼Ó °¡´ÉÇÑ ¹Ý·Áµ¿¹° °Ç°­°ü¸® ¼Ö·ç¼ÇÀÇ ºÎ»óÀ¸·Î ½Ä¹°¼º »ýºÐÇØ¼º º­·è ¹× Áøµå±â ÅðÄ¡ ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀÔ´Ï´Ù. ¹Ý·Áµ¿¹° »çÀ°·üÀÌ Áõ°¡Çϰí ÇコÄÉ¾î ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó º­·è Áøµå±â ±¸ÃæÁ¦´Â µ¿¹° ÀÇ·á¿¡ ÀÖ¾î ÇʼöÀûÀÎ Á¸Àç·Î ³²À» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(Ãò¾îºí, ½ºÇÁ·¹ÀÌ, ±âŸ Á¦Ç° À¯Çü);¾àÁ¦ À¯Çü(󹿾à, OTC);µ¿¹° À¯Çü(°³, °í¾çÀÌ, ±âŸ µ¿¹° À¯Çü);À¯Åë ä³Î(¼öÀÇ»ç, µå·°£¦¾à±¹, ¹Ý·Áµ¿¹° Àü¹®Á¡, ½´ÆÛ¸¶ÄÏ ¹× ÇÏÀÌÆÛ¸¶ÄÏ, ¿Â¶óÀÎ, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°è °íÀ¯ SLM¿¡ Äõ¸®-ÇÏ´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Flea and Tick Control Medication Market to Reach US$10.0 Billion by 2030

The global market for Flea and Tick Control Medication estimated at US$7.0 Billion in the year 2024, is expected to reach US$10.0 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Chewables, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$6.4 Billion by the end of the analysis period. Growth in the Sprays segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 10.0% CAGR

The Flea and Tick Control Medication market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Flea and Tick Control Medication Market - Key Trends & Drivers Summarized

Why Is the Demand for Flea and Tick Control Medication Increasing?

The flea and tick control medication market is expanding rapidly due to increasing pet ownership, rising awareness about pet health, and the growing prevalence of flea- and tick-borne diseases. These external parasites pose severe health risks to pets, including skin infections, anemia, and vector-borne diseases like Lyme disease and ehrlichiosis. With urbanization leading to closer human-animal interactions, there is heightened concern about zoonotic disease transmission, driving demand for effective flea and tick control solutions. Additionally, the expansion of pet insurance coverage and veterinary healthcare services has made high-quality parasitic treatments more accessible. As pet owners prioritize preventive care, the flea and tick control medication market is experiencing sustained growth.

What Technological Advancements Are Improving Flea and Tick Control Medications?

Innovations in veterinary pharmaceuticals, biotechnology, and sustained-release formulations are enhancing flea and tick control medication effectiveness. The development of long-lasting oral treatments, such as chewable tablets containing isoxazolines, provides month-long protection with improved pet compliance. Additionally, topical solutions with improved waterproof formulations ensure prolonged efficacy even after bathing or swimming. AI-driven drug discovery is enabling the development of new active ingredients that target flea and tick nervous systems with greater specificity, reducing side effects. Furthermore, advancements in insect growth regulators (IGRs) and biological control agents, such as naturally derived repellents, are providing safer alternatives to traditional chemical-based treatments. These technological innovations are making flea and tick control more effective, convenient, and pet-friendly.

How Are Regulations and Market Trends Influencing Flea and Tick Control Medication?

Regulatory authorities such as the FDA (U.S.), EMA (Europe), and APVMA (Australia) set stringent guidelines for the safety and efficacy of flea and tick control products. The increasing shift toward natural and organic pet care is driving demand for botanical-based flea repellents and essential oil-infused formulations. Additionally, the rise of subscription-based pet care services is making flea and tick medications more accessible through online veterinary platforms. The growth of the premium pet healthcare segment is fueling demand for combination treatments that offer multi-parasite protection against fleas, ticks, heartworms, and intestinal parasites. As consumer awareness and regulatory oversight increase, the market is shifting toward safer, more effective, and easily administered treatments.

What’s Driving the Future Growth of the Flea and Tick Control Medication Market?

The future of flea and tick control medications is being shaped by AI-assisted veterinary drug development, advancements in long-acting formulations, and the increasing adoption of pet telemedicine services. The integration of smart pet collars with embedded sensors capable of detecting flea and tick activity in real time is expected to revolutionize parasite control. The expansion of global pet healthcare markets, particularly in developing regions, will create new opportunities for affordable, high-efficacy treatments. Additionally, the rise of sustainable pet healthcare solutions will drive demand for plant-based and biodegradable flea and tick control options. As pet ownership rises and healthcare technology advances, flea and tick control medications will remain essential in veterinary medicine.

SCOPE OF STUDY:

The report analyzes the Flea and Tick Control Medication market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Chewables, Sprays, Other product types); Medication Type (Prescription, OTC); Animal Type (Dogs, Cats, Other animal types); Distribution Channel (Veterinarian, Drug & pharmacy stores, Pet specialty stores, Supermarkets / hypermarkets, Online, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â